Ecolab exhibits steady revenue growth, with 2025 sales of $16.1B (up 2.2% YoY), and operating margin expansion, but diluted EPS declined from $7.37 to $7.28 as higher debt costs weighed on net income. The stock remains below its 50‑day and 200‑day moving averages, and trades at a significant EV/EBITDA premium of 24.3x versus a peer median of 10.0x. Hold for the defensive franchise and 89‑year dividend history, while awaiting a better entry point or a clear re‑acceleration in earnings.